LogicBio Therapeutics (LOGC) – FDA
-
LogicBio Therapeutics (LOGC) Reports Publication of Pre-Clinical Results for mLB-001
-
LogicBio Therapeutics (LOGC) Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic Acidemia
-
-
-
-
-
-
-
-
Back to LOGC Stock Lookup